SOLUBILITY ENHANCEMENT OF ATAZANAVIR BY HYDROTROPIC SOLUBILIZATION TECHNIQUE

Authors

  • VIJAYARAGAVAN KRISHNAN Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India https://orcid.org/0009-0007-5367-1923
  • THAMARAI SELVAN DHANDAPANI Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India https://orcid.org/0009-0004-8450-4982
  • RAAGUL SEENIVASAN Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India https://orcid.org/0000-0002-3763-3528
  • SARVESH R. Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India
  • SUKESHAN M. P. Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India
  • SARAVANA KUMAR C. A. Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India https://orcid.org/0009-0007-0812-1551
  • DHANDAPANI NAGASAMY VENKATESH Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher, Education and Research, Ooty, Nilgiris, Tamilnadu, India https://orcid.org/0000-0002-5361-3586

DOI:

https://doi.org/10.22159/ijap.2024v16i2.49884

Keywords:

Atazanavir sulfate, Hydrotropy, Solubility enhancement, Kinetics, Dissolution

Abstract

Objective: The present study aims to increase the solubility and dissolution of atazanavir sulfate (ATZ) by employing a hydrotropic solubilization technique.

Methods: ATZ is a poorly soluble drug classified under the biopharmaceutical classification system (BCS)-II, which accounts for its poor oral bioavailability. Different hydrotropic agents, such as urea and sodium benzoate and their combinations at different ratios were prepared. The prepared hydrotropes were systematically investigated for compatibility between the drug and excipients using Fourier Transform Infra-Red Spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC) approaches. Further, in order to understand the conversion from crystalline to amorphous nature, X-ray Diffraction (XRD) and Scanning Electron Microscopy (SEM) studies were also performed. The formulation of a mixed hydrotropic mixture comprising urea (2.5% w/v) and sodium benzoate (5% w/v) exhibited a 100.35±1.7 % drug release at 0.25 h with higher dissolution efficiency as compared with other batches of individual hydrotrope, mixed hydrotropes as well as pure drug.

Results: FTIR studies revealed that there is no incompatibility between the drug and the selected hydrotropes. DSC studies also confirmed the fact that there is no interaction between the drug and the hydrotropes by the disappearance of an endothermic peak. XRD studies revealed that there was a significant reduction in the intensity of peaks, indicating the conversion of crystalline to the amorphous form. The SEM studies indicated that the drug appears crystalline in the shape of an irregular tiny prismatic needle, indicating its crystallinity. At the same time, the hydrotrope mixtures appeared in agglomerated form with a porous nature, which may be accountable for its increase in solubility. The hydrotropes prepared using urea alone exhibited an increase in solubility of 4.42 folds, and the hydrotrope prepared using sodium benzoate alone exhibited an increase in solubility of 3.178 folds; the combination hydrotropes of urea and sodium benzoate exhibited an increase in solubility of 8.78 folds in water as compared to pure drug. The drug release from the mixed hydrotropes obeys zero-order kinetics with diffusion as the main mechanism.

Conclusion: The present investigation concluded that the combination of hydrotropes enhanced the solubility of the aqueous soluble drug ATZ. However, in vivo studies are essential to establish its potential effect.

Downloads

Download data is not yet available.

References

Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-20. doi: 10.1023/a:1016212804288, PMID 7617530.

Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47-60. doi: 10.1016/s0939-6411(00)00076-x, PMID 10840192.

Bhandare R, Londhe V, Ashames A, Shaikh N, Alabdin SZ. Enhanced solubility of microwave-assisted synthesized acyclovir co-crystals. Res J Pharm Technol. 2020;13(12):5979-86. doi: 10.5958/0974-360X.2020.01043.4.

Behera AL, Sahoo SK, Patil SV. Enhancement of solubility: a pharmaceutical overview. Pharm Lett. 2010;2(2):310-8.

Srivastava A, Khan MA, Bedi S, Bhandari U. Design, optimization, and characterization of a novel amorphous solid dispersion formulation for enhancement of solubility and dissolution of ticagrelor. Int J App Pharm. 2023;15(4):296-305. doi: 10.22159/ijap.2023v15i4.47618.

Sahu VK, Sharma N, Sahu PK, Saraf SA. Formulation and evaluation of floating-mucoadhesive microspheres of novel natural polysaccharide for site-specific delivery of ranitidine hydrochloride. Int J App Pharm. 2017;9(3):15-9. doi: 10.22159/ijap.2017v9i3.16137.

Thenesh Kumar S, Oslin Sebastian SCR. Efficacy of hydrotropes on the solubility of forskolin in water. Int J Appl Pharm. 2016;8(2):1-4. doi: 10.22159/ijap.2016v8i2.10419.

Lee J, Lee SC, Acharya G, Chang CJ, Park K. Hydrotropic solubilization of paclitaxel: analysis of chemical structures for the hydrotropic property. Pharm Res. 2003;20(7):1022-30. doi: 10.1023/a:1024458206032, PMID 12880288.

Bajait MG. Importance of solubility and solubility enhancement techniques. JMPAS. 2019;8(6):2403-16. doi: 10.22270/ jmpas.v8i6.878.

Jayakumar C, Morais AP. Solubility enhancement of theophylline drug using different solubilization techniques. Int J Pharm Pharm Sci. 2012;2:7-10.

Pomerantz RJ, Horn DL. Twenty years of therapy for HIV-1 infection. Nat Med. 2003;9(7):867-73. doi: 10.1038/nm0703-867, PMID 12835707.

Singh G, Pai RS. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal. Drug Deliv. 2016;23(2):532-9. doi: 10.3109/10717544.2014.930760, PMID 24963752.

Pond SM, Tozer TN. First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet. 1984;9(1):1-25. doi: 10.2165/00003088-198409010-00001, PMID 6362950.

Raagul Seenivasan, Sriram Suresh Iyer, Venkatesh Prasath Narayanasamy, Vijayaraghavan Krishnan, Micah Issac Anand, Dhandapani Nagasamy Venkatesh. Solubility enhancement of terbinafine hydrochloride by hydrotropic technique. JMPAS. 2023;12(1):5596-603. doi: 10.55522/jmpas.V12I1.4067.

Dhandapani Nagasamy Venkatesh, Radhakrishnan A. Dissolution enhancement of raloxifene using water-soluble carrier by solid dispersion technology. Asian J Pharm. 2018;12(1): S346-55.

Borawake PD, Arumugam K, Shinde JV. Formulation of solid dispersions for enhancement of solubility and dissolution rate of simvastatin. Int J Pharm Pharm Sci. 2021 Jul 1;13(7):94-100. doi: 10.22159/ijpps.2021v13i7.41205.

Hardikar SR, Mulla SS. Optimization of formulation of solid dispersion of furosemide by factorial design. Int J Pharm Pharm Sci. 2020 Apr;12(4):43-8. doi: 10.22159/ijpps.2020v12i4.36428.

Mannem V, Suryadevara V, Doppalapudi S. Formulation and evaluation of telmisartan solid dispersions using Entada scandens seed starch and poloxamer-188 as superdisintegrants. Asian J Pharm Clin Res. 2018 Sep;11(9):474-81. doi: 10.22159/ajpcr.2018.v11i9.28422.

Kaushik R, Verma R, Budhwar V, Kaushik D. Investigation of solid dispersion approach for the improvement of pharmaceutical characteristics of telmisartan using a central composite design. Int J App Pharm. 2023;15(5):245-54. doi: 10.22159/ijap.2023v15i5.47968.

Kar A, Ahmed AB. Enhancement of solubility and dissolution of ibuprofen by solid dispersion technique and formulation of sustained release tablets containing the optimised batch of solid dispersion. Int J Curr Pharm Sci. 2017 Sep;9(5):37-44. doi: 10.22159/ijcpr.2017v9i5.22134.

Published

07-03-2024

How to Cite

KRISHNAN, V., DHANDAPANI, T. S., SEENIVASAN, R., R., S., M. P., S., C. A., S. K., & VENKATESH, D. N. (2024). SOLUBILITY ENHANCEMENT OF ATAZANAVIR BY HYDROTROPIC SOLUBILIZATION TECHNIQUE. International Journal of Applied Pharmaceutics, 16(2), 139–145. https://doi.org/10.22159/ijap.2024v16i2.49884

Issue

Section

Original Article(s)

Most read articles by the same author(s)